NCT05361824View on ClinicalTrials.gov

Ketorolac-an Option for Post Operative Pain Management After Elective Cardiac Surgery.

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

June 30, 2021

Study Completion Date

July 6, 2021

Conditions
Coronary Artery DiseasePost Operative PainAnalgesiaCoronary Artery Bypass Grafting Surgery
Interventions
DRUG

Ketorolac Injection

dosage form: intravenous dosage: 30mg frequency: 8 hours apart (TDS) duration: for 48 hours post operatively

DRUG

Paracetamol

dosage form: intravenous dosage: 1gm frequency: 6 hours apart (QID) duration: for 48 hours post operatively

Trial Locations (1)

Unknown

National Institute of Cardiovascular Diseases, Karachi

All Listed Sponsors
lead

National Institute of Cardiovascular Diseases, Pakistan

OTHER

NCT05361824 - Ketorolac-an Option for Post Operative Pain Management After Elective Cardiac Surgery. | Biotech Hunter | Biotech Hunter